nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—osteoarthritis—Prednisone—psoriasis	0.398	1	CpDpCtD
Flurbiprofen—UGT1A9—Mycophenolic acid—psoriasis	0.0694	0.157	CbGbCtD
Flurbiprofen—UGT2B7—Mycophenolic acid—psoriasis	0.0657	0.149	CbGbCtD
Flurbiprofen—UGT1A1—Mycophenolic acid—psoriasis	0.0568	0.129	CbGbCtD
Flurbiprofen—UGT1A9—Mycophenolate mofetil—psoriasis	0.0388	0.0879	CbGbCtD
Flurbiprofen—UGT2B7—Mycophenolate mofetil—psoriasis	0.0367	0.0832	CbGbCtD
Flurbiprofen—UGT1A1—Mycophenolate mofetil—psoriasis	0.0317	0.0719	CbGbCtD
Flurbiprofen—ALB—Acitretin—psoriasis	0.0257	0.0582	CbGbCtD
Flurbiprofen—PTGS2—Triamcinolone—psoriasis	0.0191	0.0432	CbGbCtD
Flurbiprofen—PTGS2—Betamethasone—psoriasis	0.0164	0.0371	CbGbCtD
Flurbiprofen—ABCC4—Methotrexate—psoriasis	0.013	0.0295	CbGbCtD
Flurbiprofen—ALB—Mycophenolate mofetil—psoriasis	0.012	0.0273	CbGbCtD
Flurbiprofen—SLC22A6—Cyclosporine—psoriasis	0.0107	0.0243	CbGbCtD
Flurbiprofen—ALB—Prednisone—psoriasis	0.00961	0.0218	CbGbCtD
Flurbiprofen—PTGS2—Dexamethasone—psoriasis	0.00952	0.0216	CbGbCtD
Flurbiprofen—CYP2C9—Cholecalciferol—psoriasis	0.00748	0.0169	CbGbCtD
Flurbiprofen—SLC22A6—Methotrexate—psoriasis	0.00566	0.0128	CbGbCtD
Flurbiprofen—CYP2C9—Cyclosporine—psoriasis	0.00491	0.0111	CbGbCtD
Flurbiprofen—ALB—Methotrexate—psoriasis	0.00482	0.0109	CbGbCtD
Flurbiprofen—CYP2C9—Dexamethasone—psoriasis	0.00324	0.00733	CbGbCtD
Flurbiprofen—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.000427	0.157	CbGdCrCtD
Flurbiprofen—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00037	0.047	CbGpPWpGaD
Flurbiprofen—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000342	0.126	CbGdCrCtD
Flurbiprofen—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000332	0.122	CbGdCrCtD
Flurbiprofen—Ketoprofen—CXCL8—psoriasis	0.000314	0.375	CrCbGaD
Flurbiprofen—Ibuprofen—CXCL8—psoriasis	0.000309	0.369	CrCbGaD
Flurbiprofen—UGT2B4—Biological oxidations—CYP2S1—psoriasis	0.000258	0.0329	CbGpPWpGaD
Flurbiprofen—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000257	0.0948	CbGdCrCtD
Flurbiprofen—UGT2B4—Metapathway biotransformation—CYP2S1—psoriasis	0.000255	0.0324	CbGpPWpGaD
Flurbiprofen—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000229	0.0292	CbGpPWpGaD
Flurbiprofen—Ibuprofen—PPARG—psoriasis	0.000214	0.255	CrCbGaD
Flurbiprofen—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.000206	0.076	CbGdCrCtD
Flurbiprofen—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.000206	0.076	CbGdCrCtD
Flurbiprofen—ABCC4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000205	0.0261	CbGpPWpGaD
Flurbiprofen—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.0002	0.0738	CbGdCrCtD
Flurbiprofen—PTGS2—Fluocinonide—Dexamethasone—psoriasis	0.000156	0.0574	CbGdCrCtD
Flurbiprofen—PTGS2—Fluocinonide—Betamethasone—psoriasis	0.000156	0.0574	CbGdCrCtD
Flurbiprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000154	0.0196	CbGpPWpGaD
Flurbiprofen—PTGS2—Fluocinonide—Triamcinolone—psoriasis	0.000152	0.0561	CbGdCrCtD
Flurbiprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000147	0.0187	CbGpPWpGaD
Flurbiprofen—UGT1A3—Biological oxidations—CYP2S1—psoriasis	0.000138	0.0176	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metapathway biotransformation—CYP2S1—psoriasis	0.000136	0.0174	CbGpPWpGaD
Flurbiprofen—UGT2B7—Biological oxidations—CYP2S1—psoriasis	0.000118	0.015	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metapathway biotransformation—CYP2S1—psoriasis	0.000116	0.0148	CbGpPWpGaD
Flurbiprofen—PTGS1—Overview of nanoparticle effects—CRP—psoriasis	0.000108	0.0138	CbGpPWpGaD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000107	0.0136	CbGpPWpGaD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000107	0.0136	CbGpPWpGaD
Flurbiprofen—UGT1A1—Biological oxidations—CYP2S1—psoriasis	9.56e-05	0.0122	CbGpPWpGaD
Flurbiprofen—UGT1A9—Biological oxidations—CYP2S1—psoriasis	9.56e-05	0.0122	CbGpPWpGaD
Flurbiprofen—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	9.52e-05	0.0121	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metapathway biotransformation—CYP2S1—psoriasis	9.43e-05	0.012	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metapathway biotransformation—CYP2S1—psoriasis	9.43e-05	0.012	CbGpPWpGaD
Flurbiprofen—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	9.4e-05	0.0346	CbGdCrCtD
Flurbiprofen—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	9.4e-05	0.0346	CbGdCrCtD
Flurbiprofen—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	9.39e-05	0.0119	CbGpPWpGaD
Flurbiprofen—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	9.18e-05	0.0338	CbGdCrCtD
Flurbiprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	9e-05	0.0114	CbGpPWpGaD
Flurbiprofen—PTGS2—Overview of nanoparticle effects—CRP—psoriasis	8.6e-05	0.0109	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—SERPINB8—psoriasis	8.52e-05	0.0108	CbGpPWpGaD
Flurbiprofen—ALB—HDL-mediated lipid transport—APOE—psoriasis	8.22e-05	0.0105	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	7.8e-05	0.00992	CbGpPWpGaD
Flurbiprofen—PTGS1—Biological oxidations—CYP2S1—psoriasis	7.79e-05	0.00992	CbGpPWpGaD
Flurbiprofen—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	7.71e-05	0.00981	CbGpPWpGaD
Flurbiprofen—UGT1A3—NRF2 pathway—TGFA—psoriasis	7.7e-05	0.0098	CbGpPWpGaD
Flurbiprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—psoriasis	7.09e-05	0.00902	CbGpPWpGaD
Flurbiprofen—PTGS1—Overview of nanoparticle effects—CXCL8—psoriasis	7.04e-05	0.00896	CbGpPWpGaD
Flurbiprofen—UGT1A9—PPARA activates gene expression—CARM1—psoriasis	6.68e-05	0.00849	CbGpPWpGaD
Flurbiprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	6.63e-05	0.00843	CbGpPWpGaD
Flurbiprofen—UGT2B7—NRF2 pathway—TGFA—psoriasis	6.55e-05	0.00833	CbGpPWpGaD
Flurbiprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	6.53e-05	0.00831	CbGpPWpGaD
Flurbiprofen—ABCC4—NRF2 pathway—TGFA—psoriasis	6.16e-05	0.00784	CbGpPWpGaD
Flurbiprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	5.96e-05	0.00759	CbGpPWpGaD
Flurbiprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	5.74e-05	0.0073	CbGpPWpGaD
Flurbiprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	5.73e-05	0.00729	CbGpPWpGaD
Flurbiprofen—PTGS2—Overview of nanoparticle effects—CXCL8—psoriasis	5.59e-05	0.00711	CbGpPWpGaD
Flurbiprofen—UGT1A9—NRF2 pathway—TGFA—psoriasis	5.32e-05	0.00677	CbGpPWpGaD
Flurbiprofen—UGT1A1—NRF2 pathway—TGFA—psoriasis	5.32e-05	0.00677	CbGpPWpGaD
Flurbiprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	5.21e-05	0.00663	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—NDUFA5—psoriasis	5.2e-05	0.00661	CbGpPWpGaD
Flurbiprofen—PTGS1—Overview of nanoparticle effects—TNF—psoriasis	4.9e-05	0.00624	CbGpPWpGaD
Flurbiprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	4.81e-05	0.00612	CbGpPWpGaD
Flurbiprofen—ALB—Lipoprotein metabolism—APOE—psoriasis	4.72e-05	0.00601	CbGpPWpGaD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—psoriasis	4.59e-05	0.00584	CbGpPWpGaD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.58e-05	0.00583	CbGpPWpGaD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.58e-05	0.00583	CbGpPWpGaD
Flurbiprofen—PTGS2—S1P1 pathway—VEGFA—psoriasis	4.54e-05	0.00578	CbGpPWpGaD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	4.5e-05	0.00573	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—CYP2S1—psoriasis	4.42e-05	0.00562	CbGpPWpGaD
Flurbiprofen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.37e-05	0.00556	CbGpPWpGaD
Flurbiprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.29e-05	0.00546	CbGpPWpGaD
Flurbiprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—psoriasis	4.29e-05	0.00545	CbGpPWpGaD
Flurbiprofen—CYP2C9—Biological oxidations—CYP2S1—psoriasis	4.1e-05	0.00521	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	4.04e-05	0.00514	CbGpPWpGaD
Flurbiprofen—Shock—Triamcinolone—psoriasis	4e-05	0.000268	CcSEcCtD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—CAT—psoriasis	4e-05	0.00509	CbGpPWpGaD
Flurbiprofen—Insomnia—Prednisolone—psoriasis	4e-05	0.000268	CcSEcCtD
Flurbiprofen—Alopecia—Prednisone—psoriasis	4e-05	0.000268	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Cyclosporine—psoriasis	3.98e-05	0.000266	CcSEcCtD
Flurbiprofen—Loss of consciousness—Betamethasone—psoriasis	3.98e-05	0.000266	CcSEcCtD
Flurbiprofen—Loss of consciousness—Dexamethasone—psoriasis	3.98e-05	0.000266	CcSEcCtD
Flurbiprofen—Dizziness—Mycophenolic acid—psoriasis	3.97e-05	0.000266	CcSEcCtD
Flurbiprofen—Epistaxis—Methotrexate—psoriasis	3.97e-05	0.000266	CcSEcCtD
Flurbiprofen—Paraesthesia—Prednisolone—psoriasis	3.97e-05	0.000266	CcSEcCtD
Flurbiprofen—Tachycardia—Triamcinolone—psoriasis	3.97e-05	0.000266	CcSEcCtD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.96e-05	0.00504	CbGpPWpGaD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.96e-05	0.00504	CbGpPWpGaD
Flurbiprofen—PTGS1—Overview of nanoparticle effects—IL6—psoriasis	3.96e-05	0.00503	CbGpPWpGaD
Flurbiprofen—ABCC4—Fluoropyrimidine Activity—TP53—psoriasis	3.94e-05	0.00502	CbGpPWpGaD
Flurbiprofen—Musculoskeletal discomfort—Hydrocortisone—psoriasis	3.94e-05	0.000264	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Triamcinolone—psoriasis	3.93e-05	0.000263	CcSEcCtD
Flurbiprofen—Agranulocytosis—Methotrexate—psoriasis	3.93e-05	0.000263	CcSEcCtD
Flurbiprofen—Convulsion—Dexamethasone—psoriasis	3.92e-05	0.000262	CcSEcCtD
Flurbiprofen—Convulsion—Betamethasone—psoriasis	3.92e-05	0.000262	CcSEcCtD
Flurbiprofen—Feeling abnormal—Mycophenolate mofetil—psoriasis	3.91e-05	0.000262	CcSEcCtD
Flurbiprofen—Insomnia—Hydrocortisone—psoriasis	3.91e-05	0.000262	CcSEcCtD
Flurbiprofen—Hypertension—Dexamethasone—psoriasis	3.91e-05	0.000262	CcSEcCtD
Flurbiprofen—Hypertension—Betamethasone—psoriasis	3.91e-05	0.000262	CcSEcCtD
Flurbiprofen—PTGS2—Overview of nanoparticle effects—TNF—psoriasis	3.89e-05	0.00495	CbGpPWpGaD
Flurbiprofen—Paraesthesia—Hydrocortisone—psoriasis	3.88e-05	0.00026	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	3.88e-05	0.00026	CcSEcCtD
Flurbiprofen—Urticaria—Cyclosporine—psoriasis	3.86e-05	0.000259	CcSEcCtD
Flurbiprofen—ALB—Hemostasis—SERPINB8—psoriasis	3.85e-05	0.0049	CbGpPWpGaD
Flurbiprofen—Myalgia—Betamethasone—psoriasis	3.85e-05	0.000258	CcSEcCtD
Flurbiprofen—Myalgia—Dexamethasone—psoriasis	3.85e-05	0.000258	CcSEcCtD
Flurbiprofen—Body temperature increased—Cyclosporine—psoriasis	3.84e-05	0.000257	CcSEcCtD
Flurbiprofen—Abdominal pain—Cyclosporine—psoriasis	3.84e-05	0.000257	CcSEcCtD
Flurbiprofen—Anxiety—Betamethasone—psoriasis	3.84e-05	0.000257	CcSEcCtD
Flurbiprofen—Anxiety—Dexamethasone—psoriasis	3.84e-05	0.000257	CcSEcCtD
Flurbiprofen—Vomiting—Mycophenolic acid—psoriasis	3.82e-05	0.000256	CcSEcCtD
Flurbiprofen—Discomfort—Betamethasone—psoriasis	3.8e-05	0.000255	CcSEcCtD
Flurbiprofen—Discomfort—Dexamethasone—psoriasis	3.8e-05	0.000255	CcSEcCtD
Flurbiprofen—Dyspepsia—Hydrocortisone—psoriasis	3.8e-05	0.000255	CcSEcCtD
Flurbiprofen—Haemoglobin—Methotrexate—psoriasis	3.8e-05	0.000255	CcSEcCtD
Flurbiprofen—Rash—Mycophenolic acid—psoriasis	3.79e-05	0.000254	CcSEcCtD
Flurbiprofen—Dermatitis—Mycophenolic acid—psoriasis	3.79e-05	0.000254	CcSEcCtD
Flurbiprofen—Pain—Prednisolone—psoriasis	3.78e-05	0.000253	CcSEcCtD
Flurbiprofen—Hepatitis—Methotrexate—psoriasis	3.78e-05	0.000253	CcSEcCtD
Flurbiprofen—Haemorrhage—Methotrexate—psoriasis	3.78e-05	0.000253	CcSEcCtD
Flurbiprofen—Urticaria—Mycophenolate mofetil—psoriasis	3.77e-05	0.000252	CcSEcCtD
Flurbiprofen—Headache—Mycophenolic acid—psoriasis	3.77e-05	0.000252	CcSEcCtD
Flurbiprofen—Decreased appetite—Hydrocortisone—psoriasis	3.76e-05	0.000252	CcSEcCtD
Flurbiprofen—Pharyngitis—Methotrexate—psoriasis	3.75e-05	0.000251	CcSEcCtD
Flurbiprofen—Body temperature increased—Mycophenolate mofetil—psoriasis	3.75e-05	0.000251	CcSEcCtD
Flurbiprofen—Abdominal pain—Mycophenolate mofetil—psoriasis	3.75e-05	0.000251	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.71e-05	0.000248	CcSEcCtD
Flurbiprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—psoriasis	3.71e-05	0.00471	CbGpPWpGaD
Flurbiprofen—Pain—Hydrocortisone—psoriasis	3.7e-05	0.000247	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Betamethasone—psoriasis	3.69e-05	0.000247	CcSEcCtD
Flurbiprofen—Oedema—Dexamethasone—psoriasis	3.69e-05	0.000247	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Dexamethasone—psoriasis	3.69e-05	0.000247	CcSEcCtD
Flurbiprofen—Oedema—Betamethasone—psoriasis	3.69e-05	0.000247	CcSEcCtD
Flurbiprofen—Insomnia—Triamcinolone—psoriasis	3.68e-05	0.000246	CcSEcCtD
Flurbiprofen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	3.68e-05	0.00468	CbGpPWpGaD
Flurbiprofen—Infection—Betamethasone—psoriasis	3.67e-05	0.000246	CcSEcCtD
Flurbiprofen—Infection—Dexamethasone—psoriasis	3.67e-05	0.000246	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Prednisone—psoriasis	3.66e-05	0.000245	CcSEcCtD
Flurbiprofen—Paraesthesia—Triamcinolone—psoriasis	3.65e-05	0.000245	CcSEcCtD
Flurbiprofen—Feeling abnormal—Prednisolone—psoriasis	3.65e-05	0.000244	CcSEcCtD
Flurbiprofen—Visual impairment—Methotrexate—psoriasis	3.64e-05	0.000244	CcSEcCtD
Flurbiprofen—Anaemia—Prednisone—psoriasis	3.64e-05	0.000244	CcSEcCtD
Flurbiprofen—Shock—Betamethasone—psoriasis	3.63e-05	0.000243	CcSEcCtD
Flurbiprofen—Shock—Dexamethasone—psoriasis	3.63e-05	0.000243	CcSEcCtD
Flurbiprofen—Dyspnoea—Triamcinolone—psoriasis	3.63e-05	0.000243	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Dexamethasone—psoriasis	3.61e-05	0.000242	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Betamethasone—psoriasis	3.61e-05	0.000242	CcSEcCtD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	3.61e-05	0.0046	CbGpPWpGaD
Flurbiprofen—Tachycardia—Betamethasone—psoriasis	3.6e-05	0.000241	CcSEcCtD
Flurbiprofen—Tachycardia—Dexamethasone—psoriasis	3.6e-05	0.000241	CcSEcCtD
Flurbiprofen—Angioedema—Prednisone—psoriasis	3.6e-05	0.000241	CcSEcCtD
Flurbiprofen—Hypersensitivity—Cyclosporine—psoriasis	3.58e-05	0.00024	CcSEcCtD
Flurbiprofen—Dyspepsia—Triamcinolone—psoriasis	3.58e-05	0.00024	CcSEcCtD
Flurbiprofen—Erythema multiforme—Methotrexate—psoriasis	3.58e-05	0.000239	CcSEcCtD
Flurbiprofen—Nausea—Mycophenolic acid—psoriasis	3.57e-05	0.000239	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Betamethasone—psoriasis	3.57e-05	0.000239	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Dexamethasone—psoriasis	3.57e-05	0.000239	CcSEcCtD
Flurbiprofen—Feeling abnormal—Hydrocortisone—psoriasis	3.56e-05	0.000238	CcSEcCtD
Flurbiprofen—Malaise—Prednisone—psoriasis	3.55e-05	0.000238	CcSEcCtD
Flurbiprofen—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	3.54e-05	0.00451	CbGpPWpGaD
Flurbiprofen—Vertigo—Prednisone—psoriasis	3.54e-05	0.000237	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Hydrocortisone—psoriasis	3.53e-05	0.000237	CcSEcCtD
Flurbiprofen—Syncope—Prednisone—psoriasis	3.53e-05	0.000237	CcSEcCtD
Flurbiprofen—Tinnitus—Methotrexate—psoriasis	3.53e-05	0.000236	CcSEcCtD
Flurbiprofen—Anorexia—Dexamethasone—psoriasis	3.52e-05	0.000236	CcSEcCtD
Flurbiprofen—Anorexia—Betamethasone—psoriasis	3.52e-05	0.000236	CcSEcCtD
Flurbiprofen—Urticaria—Prednisolone—psoriasis	3.51e-05	0.000235	CcSEcCtD
Flurbiprofen—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.49e-05	0.000234	CcSEcCtD
Flurbiprofen—Asthenia—Cyclosporine—psoriasis	3.49e-05	0.000234	CcSEcCtD
Flurbiprofen—Pain—Triamcinolone—psoriasis	3.48e-05	0.000233	CcSEcCtD
Flurbiprofen—Loss of consciousness—Prednisone—psoriasis	3.46e-05	0.000232	CcSEcCtD
Flurbiprofen—Hypotension—Betamethasone—psoriasis	3.45e-05	0.000231	CcSEcCtD
Flurbiprofen—Hypotension—Dexamethasone—psoriasis	3.45e-05	0.000231	CcSEcCtD
Flurbiprofen—Pruritus—Cyclosporine—psoriasis	3.44e-05	0.00023	CcSEcCtD
Flurbiprofen—Urticaria—Hydrocortisone—psoriasis	3.43e-05	0.00023	CcSEcCtD
Flurbiprofen—Angiopathy—Methotrexate—psoriasis	3.43e-05	0.00023	CcSEcCtD
Flurbiprofen—Abdominal pain—Hydrocortisone—psoriasis	3.42e-05	0.000229	CcSEcCtD
Flurbiprofen—Body temperature increased—Hydrocortisone—psoriasis	3.42e-05	0.000229	CcSEcCtD
Flurbiprofen—Convulsion—Prednisone—psoriasis	3.41e-05	0.000229	CcSEcCtD
Flurbiprofen—Asthenia—Mycophenolate mofetil—psoriasis	3.4e-05	0.000228	CcSEcCtD
Flurbiprofen—Hypertension—Prednisone—psoriasis	3.4e-05	0.000228	CcSEcCtD
Flurbiprofen—Chills—Methotrexate—psoriasis	3.39e-05	0.000227	CcSEcCtD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—psoriasis	3.38e-05	0.0043	CbGpPWpGaD
Flurbiprofen—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.36e-05	0.000225	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Betamethasone—psoriasis	3.36e-05	0.000225	CcSEcCtD
Flurbiprofen—Pruritus—Mycophenolate mofetil—psoriasis	3.36e-05	0.000225	CcSEcCtD
Flurbiprofen—Myalgia—Prednisone—psoriasis	3.35e-05	0.000225	CcSEcCtD
Flurbiprofen—Feeling abnormal—Triamcinolone—psoriasis	3.35e-05	0.000225	CcSEcCtD
Flurbiprofen—Anxiety—Prednisone—psoriasis	3.34e-05	0.000224	CcSEcCtD
Flurbiprofen—Alopecia—Methotrexate—psoriasis	3.34e-05	0.000224	CcSEcCtD
Flurbiprofen—Insomnia—Dexamethasone—psoriasis	3.34e-05	0.000224	CcSEcCtD
Flurbiprofen—Insomnia—Betamethasone—psoriasis	3.34e-05	0.000224	CcSEcCtD
Flurbiprofen—Diarrhoea—Cyclosporine—psoriasis	3.33e-05	0.000223	CcSEcCtD
Flurbiprofen—Paraesthesia—Betamethasone—psoriasis	3.31e-05	0.000222	CcSEcCtD
Flurbiprofen—Paraesthesia—Dexamethasone—psoriasis	3.31e-05	0.000222	CcSEcCtD
Flurbiprofen—Discomfort—Prednisone—psoriasis	3.31e-05	0.000222	CcSEcCtD
Flurbiprofen—Hypersensitivity—Prednisolone—psoriasis	3.26e-05	0.000218	CcSEcCtD
Flurbiprofen—Dyspepsia—Dexamethasone—psoriasis	3.25e-05	0.000218	CcSEcCtD
Flurbiprofen—Dyspepsia—Betamethasone—psoriasis	3.25e-05	0.000218	CcSEcCtD
Flurbiprofen—Diarrhoea—Mycophenolate mofetil—psoriasis	3.25e-05	0.000217	CcSEcCtD
Flurbiprofen—ALB—Folate Metabolism—CAT—psoriasis	3.24e-05	0.00412	CbGpPWpGaD
Flurbiprofen—Urticaria—Triamcinolone—psoriasis	3.23e-05	0.000216	CcSEcCtD
Flurbiprofen—Body temperature increased—Triamcinolone—psoriasis	3.22e-05	0.000215	CcSEcCtD
Flurbiprofen—Dizziness—Cyclosporine—psoriasis	3.22e-05	0.000215	CcSEcCtD
Flurbiprofen—Oedema—Prednisone—psoriasis	3.21e-05	0.000215	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Prednisone—psoriasis	3.21e-05	0.000215	CcSEcCtD
Flurbiprofen—Decreased appetite—Dexamethasone—psoriasis	3.21e-05	0.000215	CcSEcCtD
Flurbiprofen—Decreased appetite—Betamethasone—psoriasis	3.21e-05	0.000215	CcSEcCtD
Flurbiprofen—Infection—Prednisone—psoriasis	3.19e-05	0.000214	CcSEcCtD
Flurbiprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	3.19e-05	0.00406	CbGpPWpGaD
Flurbiprofen—Hypersensitivity—Hydrocortisone—psoriasis	3.18e-05	0.000213	CcSEcCtD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	3.18e-05	0.00404	CbGpPWpGaD
Flurbiprofen—PTGS2—Selenium Micronutrient Network—CAT—psoriasis	3.18e-05	0.00404	CbGpPWpGaD
Flurbiprofen—Shock—Prednisone—psoriasis	3.16e-05	0.000212	CcSEcCtD
Flurbiprofen—ALB—Vitamin B12 Metabolism—CRP—psoriasis	3.16e-05	0.00402	CbGpPWpGaD
Flurbiprofen—Pain—Dexamethasone—psoriasis	3.16e-05	0.000211	CcSEcCtD
Flurbiprofen—Pain—Betamethasone—psoriasis	3.16e-05	0.000211	CcSEcCtD
Flurbiprofen—PTGS2—Overview of nanoparticle effects—IL6—psoriasis	3.14e-05	0.004	CbGpPWpGaD
Flurbiprofen—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	3.14e-05	0.00399	CbGpPWpGaD
Flurbiprofen—Tachycardia—Prednisone—psoriasis	3.14e-05	0.00021	CcSEcCtD
Flurbiprofen—Dizziness—Mycophenolate mofetil—psoriasis	3.14e-05	0.00021	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Prednisone—psoriasis	3.11e-05	0.000208	CcSEcCtD
Flurbiprofen—Asthenia—Hydrocortisone—psoriasis	3.1e-05	0.000208	CcSEcCtD
Flurbiprofen—Vomiting—Cyclosporine—psoriasis	3.09e-05	0.000207	CcSEcCtD
Flurbiprofen—ALB—Vitamin B12 Metabolism—APOE—psoriasis	3.09e-05	0.00393	CbGpPWpGaD
Flurbiprofen—Rash—Cyclosporine—psoriasis	3.07e-05	0.000205	CcSEcCtD
Flurbiprofen—Anorexia—Prednisone—psoriasis	3.06e-05	0.000205	CcSEcCtD
Flurbiprofen—Dermatitis—Cyclosporine—psoriasis	3.06e-05	0.000205	CcSEcCtD
Flurbiprofen—Pruritus—Hydrocortisone—psoriasis	3.06e-05	0.000205	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Methotrexate—psoriasis	3.05e-05	0.000205	CcSEcCtD
Flurbiprofen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.05e-05	0.00388	CbGpPWpGaD
Flurbiprofen—Headache—Cyclosporine—psoriasis	3.05e-05	0.000204	CcSEcCtD
Flurbiprofen—Anaemia—Methotrexate—psoriasis	3.04e-05	0.000204	CcSEcCtD
Flurbiprofen—Feeling abnormal—Betamethasone—psoriasis	3.04e-05	0.000204	CcSEcCtD
Flurbiprofen—Feeling abnormal—Dexamethasone—psoriasis	3.04e-05	0.000204	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Betamethasone—psoriasis	3.02e-05	0.000202	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Dexamethasone—psoriasis	3.02e-05	0.000202	CcSEcCtD
Flurbiprofen—Vomiting—Mycophenolate mofetil—psoriasis	3.02e-05	0.000202	CcSEcCtD
Flurbiprofen—Hypersensitivity—Triamcinolone—psoriasis	3e-05	0.000201	CcSEcCtD
Flurbiprofen—Rash—Mycophenolate mofetil—psoriasis	2.99e-05	0.0002	CcSEcCtD
Flurbiprofen—Dermatitis—Mycophenolate mofetil—psoriasis	2.99e-05	0.0002	CcSEcCtD
Flurbiprofen—ALB—Folate Metabolism—IL4—psoriasis	2.97e-05	0.00378	CbGpPWpGaD
Flurbiprofen—Headache—Mycophenolate mofetil—psoriasis	2.97e-05	0.000199	CcSEcCtD
Flurbiprofen—Malaise—Methotrexate—psoriasis	2.97e-05	0.000199	CcSEcCtD
Flurbiprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.96e-05	0.00377	CbGpPWpGaD
Flurbiprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.96e-05	0.00377	CbGpPWpGaD
Flurbiprofen—Vertigo—Methotrexate—psoriasis	2.96e-05	0.000198	CcSEcCtD
Flurbiprofen—Diarrhoea—Hydrocortisone—psoriasis	2.96e-05	0.000198	CcSEcCtD
Flurbiprofen—Leukopenia—Methotrexate—psoriasis	2.95e-05	0.000197	CcSEcCtD
Flurbiprofen—Urticaria—Betamethasone—psoriasis	2.93e-05	0.000196	CcSEcCtD
Flurbiprofen—Urticaria—Dexamethasone—psoriasis	2.93e-05	0.000196	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Prednisone—psoriasis	2.93e-05	0.000196	CcSEcCtD
Flurbiprofen—Dizziness—Prednisolone—psoriasis	2.93e-05	0.000196	CcSEcCtD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	2.92e-05	0.00372	CbGpPWpGaD
Flurbiprofen—Asthenia—Triamcinolone—psoriasis	2.92e-05	0.000195	CcSEcCtD
Flurbiprofen—Abdominal pain—Betamethasone—psoriasis	2.92e-05	0.000195	CcSEcCtD
Flurbiprofen—Body temperature increased—Betamethasone—psoriasis	2.92e-05	0.000195	CcSEcCtD
Flurbiprofen—Abdominal pain—Dexamethasone—psoriasis	2.92e-05	0.000195	CcSEcCtD
Flurbiprofen—Body temperature increased—Dexamethasone—psoriasis	2.92e-05	0.000195	CcSEcCtD
Flurbiprofen—Insomnia—Prednisone—psoriasis	2.91e-05	0.000195	CcSEcCtD
Flurbiprofen—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	2.9e-05	0.00369	CbGpPWpGaD
Flurbiprofen—Nausea—Cyclosporine—psoriasis	2.89e-05	0.000193	CcSEcCtD
Flurbiprofen—Paraesthesia—Prednisone—psoriasis	2.89e-05	0.000193	CcSEcCtD
Flurbiprofen—Pruritus—Triamcinolone—psoriasis	2.88e-05	0.000193	CcSEcCtD
Flurbiprofen—Cough—Methotrexate—psoriasis	2.87e-05	0.000192	CcSEcCtD
Flurbiprofen—Dizziness—Hydrocortisone—psoriasis	2.86e-05	0.000191	CcSEcCtD
Flurbiprofen—Convulsion—Methotrexate—psoriasis	2.85e-05	0.000191	CcSEcCtD
Flurbiprofen—Dyspepsia—Prednisone—psoriasis	2.83e-05	0.00019	CcSEcCtD
Flurbiprofen—Nausea—Mycophenolate mofetil—psoriasis	2.82e-05	0.000189	CcSEcCtD
Flurbiprofen—Myalgia—Methotrexate—psoriasis	2.8e-05	0.000188	CcSEcCtD
Flurbiprofen—Decreased appetite—Prednisone—psoriasis	2.79e-05	0.000187	CcSEcCtD
Flurbiprofen—Rash—Prednisolone—psoriasis	2.79e-05	0.000187	CcSEcCtD
Flurbiprofen—Dermatitis—Prednisolone—psoriasis	2.79e-05	0.000187	CcSEcCtD
Flurbiprofen—UGT1A3—Metabolism—NDUFA5—psoriasis	2.78e-05	0.00354	CbGpPWpGaD
Flurbiprofen—UGT1A9—PPARA activates gene expression—PPARG—psoriasis	2.78e-05	0.00354	CbGpPWpGaD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	2.77e-05	0.00353	CbGpPWpGaD
Flurbiprofen—Headache—Prednisolone—psoriasis	2.77e-05	0.000186	CcSEcCtD
Flurbiprofen—Discomfort—Methotrexate—psoriasis	2.77e-05	0.000185	CcSEcCtD
Flurbiprofen—Constipation—Prednisone—psoriasis	2.75e-05	0.000184	CcSEcCtD
Flurbiprofen—Vomiting—Hydrocortisone—psoriasis	2.75e-05	0.000184	CcSEcCtD
Flurbiprofen—Rash—Hydrocortisone—psoriasis	2.72e-05	0.000182	CcSEcCtD
Flurbiprofen—Dermatitis—Hydrocortisone—psoriasis	2.72e-05	0.000182	CcSEcCtD
Flurbiprofen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	2.72e-05	0.00346	CbGpPWpGaD
Flurbiprofen—Confusional state—Methotrexate—psoriasis	2.71e-05	0.000181	CcSEcCtD
Flurbiprofen—Headache—Hydrocortisone—psoriasis	2.71e-05	0.000181	CcSEcCtD
Flurbiprofen—Dizziness—Triamcinolone—psoriasis	2.69e-05	0.00018	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Methotrexate—psoriasis	2.69e-05	0.00018	CcSEcCtD
Flurbiprofen—Infection—Methotrexate—psoriasis	2.67e-05	0.000179	CcSEcCtD
Flurbiprofen—Feeling abnormal—Prednisone—psoriasis	2.65e-05	0.000177	CcSEcCtD
Flurbiprofen—Asthenia—Betamethasone—psoriasis	2.65e-05	0.000177	CcSEcCtD
Flurbiprofen—Asthenia—Dexamethasone—psoriasis	2.65e-05	0.000177	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Methotrexate—psoriasis	2.63e-05	0.000176	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Prednisone—psoriasis	2.63e-05	0.000176	CcSEcCtD
Flurbiprofen—Nausea—Prednisolone—psoriasis	2.63e-05	0.000176	CcSEcCtD
Flurbiprofen—Pruritus—Dexamethasone—psoriasis	2.61e-05	0.000175	CcSEcCtD
Flurbiprofen—Pruritus—Betamethasone—psoriasis	2.61e-05	0.000175	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Methotrexate—psoriasis	2.6e-05	0.000174	CcSEcCtD
Flurbiprofen—Vomiting—Triamcinolone—psoriasis	2.59e-05	0.000173	CcSEcCtD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	2.58e-05	0.00328	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet degranulation—VEGFA—psoriasis	2.57e-05	0.00327	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—CAT—psoriasis	2.57e-05	0.00327	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—CRP—psoriasis	2.57e-05	0.00327	CbGpPWpGaD
Flurbiprofen—Nausea—Hydrocortisone—psoriasis	2.57e-05	0.000172	CcSEcCtD
Flurbiprofen—Rash—Triamcinolone—psoriasis	2.57e-05	0.000172	CcSEcCtD
Flurbiprofen—Dermatitis—Triamcinolone—psoriasis	2.56e-05	0.000172	CcSEcCtD
Flurbiprofen—Anorexia—Methotrexate—psoriasis	2.56e-05	0.000172	CcSEcCtD
Flurbiprofen—Urticaria—Prednisone—psoriasis	2.55e-05	0.000171	CcSEcCtD
Flurbiprofen—Headache—Triamcinolone—psoriasis	2.55e-05	0.000171	CcSEcCtD
Flurbiprofen—Body temperature increased—Prednisone—psoriasis	2.54e-05	0.00017	CcSEcCtD
Flurbiprofen—Abdominal pain—Prednisone—psoriasis	2.54e-05	0.00017	CcSEcCtD
Flurbiprofen—Diarrhoea—Betamethasone—psoriasis	2.53e-05	0.000169	CcSEcCtD
Flurbiprofen—Diarrhoea—Dexamethasone—psoriasis	2.53e-05	0.000169	CcSEcCtD
Flurbiprofen—PTGS2—Selenium Micronutrient Network—CRP—psoriasis	2.52e-05	0.00321	CbGpPWpGaD
Flurbiprofen—Hypotension—Methotrexate—psoriasis	2.51e-05	0.000168	CcSEcCtD
Flurbiprofen—ABCC4—Hemostasis—ITGAL—psoriasis	2.47e-05	0.00315	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.47e-05	0.00314	CbGpPWpGaD
Flurbiprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.45e-05	0.00312	CbGpPWpGaD
Flurbiprofen—Musculoskeletal discomfort—Methotrexate—psoriasis	2.45e-05	0.000164	CcSEcCtD
Flurbiprofen—Dizziness—Betamethasone—psoriasis	2.44e-05	0.000163	CcSEcCtD
Flurbiprofen—Dizziness—Dexamethasone—psoriasis	2.44e-05	0.000163	CcSEcCtD
Flurbiprofen—Insomnia—Methotrexate—psoriasis	2.43e-05	0.000163	CcSEcCtD
Flurbiprofen—Nausea—Triamcinolone—psoriasis	2.42e-05	0.000162	CcSEcCtD
Flurbiprofen—Paraesthesia—Methotrexate—psoriasis	2.41e-05	0.000162	CcSEcCtD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	2.4e-05	0.00305	CbGpPWpGaD
Flurbiprofen—Dyspnoea—Methotrexate—psoriasis	2.4e-05	0.00016	CcSEcCtD
Flurbiprofen—Somnolence—Methotrexate—psoriasis	2.39e-05	0.00016	CcSEcCtD
Flurbiprofen—Hypersensitivity—Prednisone—psoriasis	2.37e-05	0.000159	CcSEcCtD
Flurbiprofen—UGT1A3—Metabolism—CYP2S1—psoriasis	2.37e-05	0.00301	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—NDUFA5—psoriasis	2.37e-05	0.00301	CbGpPWpGaD
Flurbiprofen—Dyspepsia—Methotrexate—psoriasis	2.37e-05	0.000158	CcSEcCtD
Flurbiprofen—ALB—Folate Metabolism—ICAM1—psoriasis	2.36e-05	0.003	CbGpPWpGaD
Flurbiprofen—Vomiting—Dexamethasone—psoriasis	2.35e-05	0.000157	CcSEcCtD
Flurbiprofen—Vomiting—Betamethasone—psoriasis	2.35e-05	0.000157	CcSEcCtD
Flurbiprofen—Decreased appetite—Methotrexate—psoriasis	2.34e-05	0.000156	CcSEcCtD
Flurbiprofen—Rash—Dexamethasone—psoriasis	2.33e-05	0.000156	CcSEcCtD
Flurbiprofen—Rash—Betamethasone—psoriasis	2.33e-05	0.000156	CcSEcCtD
Flurbiprofen—Dermatitis—Dexamethasone—psoriasis	2.33e-05	0.000156	CcSEcCtD
Flurbiprofen—Dermatitis—Betamethasone—psoriasis	2.33e-05	0.000156	CcSEcCtD
Flurbiprofen—PTGS2—Selenium Micronutrient Network—ICAM1—psoriasis	2.32e-05	0.00295	CbGpPWpGaD
Flurbiprofen—Headache—Betamethasone—psoriasis	2.31e-05	0.000155	CcSEcCtD
Flurbiprofen—Headache—Dexamethasone—psoriasis	2.31e-05	0.000155	CcSEcCtD
Flurbiprofen—PTGS2—Spinal Cord Injury—IL4—psoriasis	2.31e-05	0.00294	CbGpPWpGaD
Flurbiprofen—Asthenia—Prednisone—psoriasis	2.31e-05	0.000154	CcSEcCtD
Flurbiprofen—Pain—Methotrexate—psoriasis	2.3e-05	0.000154	CcSEcCtD
Flurbiprofen—Pruritus—Prednisone—psoriasis	2.27e-05	0.000152	CcSEcCtD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.24e-05	0.00285	CbGpPWpGaD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	2.22e-05	0.00283	CbGpPWpGaD
Flurbiprofen—Feeling abnormal—Methotrexate—psoriasis	2.21e-05	0.000148	CcSEcCtD
Flurbiprofen—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	2.21e-05	0.00281	CbGpPWpGaD
Flurbiprofen—Diarrhoea—Prednisone—psoriasis	2.2e-05	0.000147	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Methotrexate—psoriasis	2.2e-05	0.000147	CcSEcCtD
Flurbiprofen—Nausea—Dexamethasone—psoriasis	2.19e-05	0.000147	CcSEcCtD
Flurbiprofen—Nausea—Betamethasone—psoriasis	2.19e-05	0.000147	CcSEcCtD
Flurbiprofen—UGT2B4—Metabolism—CARM1—psoriasis	2.16e-05	0.00274	CbGpPWpGaD
Flurbiprofen—Urticaria—Methotrexate—psoriasis	2.13e-05	0.000143	CcSEcCtD
Flurbiprofen—Dizziness—Prednisone—psoriasis	2.13e-05	0.000142	CcSEcCtD
Flurbiprofen—Abdominal pain—Methotrexate—psoriasis	2.12e-05	0.000142	CcSEcCtD
Flurbiprofen—Body temperature increased—Methotrexate—psoriasis	2.12e-05	0.000142	CcSEcCtD
Flurbiprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	2.1e-05	0.00268	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—CP—psoriasis	2.07e-05	0.00263	CbGpPWpGaD
Flurbiprofen—Vomiting—Prednisone—psoriasis	2.04e-05	0.000137	CcSEcCtD
Flurbiprofen—ALB—Selenium Micronutrient Network—CRP—psoriasis	2.04e-05	0.0026	CbGpPWpGaD
Flurbiprofen—Rash—Prednisone—psoriasis	2.03e-05	0.000136	CcSEcCtD
Flurbiprofen—Dermatitis—Prednisone—psoriasis	2.03e-05	0.000136	CcSEcCtD
Flurbiprofen—Headache—Prednisone—psoriasis	2.01e-05	0.000135	CcSEcCtD
Flurbiprofen—UGT2B7—Metabolism—CYP2S1—psoriasis	2.01e-05	0.00256	CbGpPWpGaD
Flurbiprofen—Hypersensitivity—Methotrexate—psoriasis	1.98e-05	0.000133	CcSEcCtD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—CARM1—psoriasis	1.97e-05	0.00251	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—LEP—psoriasis	1.95e-05	0.00248	CbGpPWpGaD
Flurbiprofen—Asthenia—Methotrexate—psoriasis	1.93e-05	0.000129	CcSEcCtD
Flurbiprofen—UGT1A1—Metabolism—NDUFA5—psoriasis	1.92e-05	0.00245	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—NDUFA5—psoriasis	1.92e-05	0.00245	CbGpPWpGaD
Flurbiprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.92e-05	0.00244	CbGpPWpGaD
Flurbiprofen—Nausea—Prednisone—psoriasis	1.91e-05	0.000128	CcSEcCtD
Flurbiprofen—Pruritus—Methotrexate—psoriasis	1.9e-05	0.000127	CcSEcCtD
Flurbiprofen—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	1.88e-05	0.00239	CbGpPWpGaD
Flurbiprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	1.87e-05	0.00238	CbGpPWpGaD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	1.85e-05	0.00235	CbGpPWpGaD
Flurbiprofen—ALB—SLC-mediated transmembrane transport—CP—psoriasis	1.84e-05	0.00234	CbGpPWpGaD
Flurbiprofen—Diarrhoea—Methotrexate—psoriasis	1.84e-05	0.000123	CcSEcCtD
Flurbiprofen—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	1.84e-05	0.00234	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—ICAM1—psoriasis	1.83e-05	0.00233	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—NOS2—psoriasis	1.82e-05	0.00231	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	1.8e-05	0.00229	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—IFNG—psoriasis	1.8e-05	0.00229	CbGpPWpGaD
Flurbiprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	1.79e-05	0.00228	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.79e-05	0.00228	CbGpPWpGaD
Flurbiprofen—Dizziness—Methotrexate—psoriasis	1.78e-05	0.000119	CcSEcCtD
Flurbiprofen—PTGS2—C-MYB transcription factor network—CD4—psoriasis	1.77e-05	0.00225	CbGpPWpGaD
Flurbiprofen—PTGS2—Selenium Micronutrient Network—IFNG—psoriasis	1.76e-05	0.00224	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	1.72e-05	0.00218	CbGpPWpGaD
Flurbiprofen—Vomiting—Methotrexate—psoriasis	1.71e-05	0.000114	CcSEcCtD
Flurbiprofen—Rash—Methotrexate—psoriasis	1.69e-05	0.000113	CcSEcCtD
Flurbiprofen—Dermatitis—Methotrexate—psoriasis	1.69e-05	0.000113	CcSEcCtD
Flurbiprofen—Headache—Methotrexate—psoriasis	1.68e-05	0.000113	CcSEcCtD
Flurbiprofen—UGT1A1—Metabolism—CYP2S1—psoriasis	1.64e-05	0.00208	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CYP2S1—psoriasis	1.64e-05	0.00208	CbGpPWpGaD
Flurbiprofen—Nausea—Methotrexate—psoriasis	1.6e-05	0.000107	CcSEcCtD
Flurbiprofen—PTGS1—Metabolism—NDUFA5—psoriasis	1.57e-05	0.00199	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—NFKB1—psoriasis	1.5e-05	0.0019	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.47e-05	0.00187	CbGpPWpGaD
Flurbiprofen—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	1.47e-05	0.00187	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.46e-05	0.00186	CbGpPWpGaD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	1.44e-05	0.00183	CbGpPWpGaD
Flurbiprofen—ALB—Vitamin B12 Metabolism—TNF—psoriasis	1.43e-05	0.00182	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—IFNG—psoriasis	1.43e-05	0.00182	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—IFNG—psoriasis	1.4e-05	0.00177	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYP2S1—psoriasis	1.33e-05	0.0017	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—CAT—psoriasis	1.33e-05	0.00169	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	1.3e-05	0.00165	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NDUFA5—psoriasis	1.24e-05	0.00158	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.24e-05	0.00157	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	1.19e-05	0.00151	CbGpPWpGaD
Flurbiprofen—ALB—Platelet degranulation—VEGFA—psoriasis	1.16e-05	0.00148	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—TNF—psoriasis	1.16e-05	0.00148	CbGpPWpGaD
Flurbiprofen—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	1.16e-05	0.00148	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.16e-05	0.00148	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—CARM1—psoriasis	1.16e-05	0.00147	CbGpPWpGaD
Flurbiprofen—ALB—Vitamin B12 Metabolism—IL6—psoriasis	1.15e-05	0.00147	CbGpPWpGaD
Flurbiprofen—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	1.14e-05	0.00145	CbGpPWpGaD
Flurbiprofen—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.14e-05	0.00145	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—ITGAL—psoriasis	1.12e-05	0.00142	CbGpPWpGaD
Flurbiprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	1.11e-05	0.00141	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP2S1—psoriasis	1.06e-05	0.00135	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—APOE—psoriasis	1.03e-05	0.00131	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—TP53—psoriasis	1.03e-05	0.0013	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—NOS2—psoriasis	1.01e-05	0.00129	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NDUFA5—psoriasis	1.01e-05	0.00128	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CARM1—psoriasis	9.83e-06	0.00125	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.39e-06	0.00119	CbGpPWpGaD
Flurbiprofen—ALB—Folate Metabolism—IL6—psoriasis	9.38e-06	0.00119	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—CP—psoriasis	9.36e-06	0.00119	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—TNF—psoriasis	9.24e-06	0.00118	CbGpPWpGaD
Flurbiprofen—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	9.22e-06	0.00117	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—TNF—psoriasis	9.03e-06	0.00115	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PPARG—psoriasis	8.98e-06	0.00114	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	8.93e-06	0.00114	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.57e-06	0.00109	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP2S1—psoriasis	8.56e-06	0.00109	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NDUFA5—psoriasis	8.24e-06	0.00105	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	8.2e-06	0.00104	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CARM1—psoriasis	7.99e-06	0.00102	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CARM1—psoriasis	7.99e-06	0.00102	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—TP53—psoriasis	7.96e-06	0.00101	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	7.9e-06	0.001	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.68e-06	0.000977	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.46e-06	0.000949	CbGpPWpGaD
Flurbiprofen—ALB—Selenium Micronutrient Network—IL6—psoriasis	7.46e-06	0.000948	CbGpPWpGaD
Flurbiprofen—PTGS2—Spinal Cord Injury—IL6—psoriasis	7.29e-06	0.000927	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	7.17e-06	0.000912	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—CAT—psoriasis	7.11e-06	0.000904	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP2S1—psoriasis	7.01e-06	0.000891	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.99e-06	0.000889	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CARM1—psoriasis	6.51e-06	0.000828	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.14e-06	0.000781	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.08e-06	0.000774	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CAT—psoriasis	6.04e-06	0.000769	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—VEGFA—psoriasis	5.88e-06	0.000748	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.55e-06	0.000705	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—APOE—psoriasis	5.52e-06	0.000703	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.42e-06	0.000689	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CARM1—psoriasis	5.17e-06	0.000657	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	5.16e-06	0.000656	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CAT—psoriasis	4.91e-06	0.000625	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CAT—psoriasis	4.91e-06	0.000625	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.83e-06	0.000614	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PPARG—psoriasis	4.81e-06	0.000612	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—APOE—psoriasis	4.7e-06	0.000597	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—NOS2—psoriasis	4.59e-06	0.000584	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.49e-06	0.000571	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TP53—psoriasis	4.44e-06	0.000565	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CARM1—psoriasis	4.18e-06	0.000532	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PPARG—psoriasis	4.09e-06	0.00052	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CAT—psoriasis	4e-06	0.000509	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.91e-06	0.000497	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—APOE—psoriasis	3.82e-06	0.000485	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—APOE—psoriasis	3.82e-06	0.000485	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.67e-06	0.000467	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CARM1—psoriasis	3.42e-06	0.000435	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PPARG—psoriasis	3.32e-06	0.000423	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PPARG—psoriasis	3.32e-06	0.000423	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.2e-06	0.000407	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CAT—psoriasis	3.18e-06	0.000404	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HLA-A—psoriasis	3.16e-06	0.000402	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—APOE—psoriasis	3.11e-06	0.000396	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—APOE—psoriasis	2.95e-06	0.000375	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NOS2—psoriasis	2.75e-06	0.00035	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PPARG—psoriasis	2.71e-06	0.000345	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—VEGFA—psoriasis	2.66e-06	0.000338	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CAT—psoriasis	2.57e-06	0.000327	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—APOE—psoriasis	2.47e-06	0.000314	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TYK2—psoriasis	2.25e-06	0.000286	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PPARG—psoriasis	2.15e-06	0.000274	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CAT—psoriasis	2.1e-06	0.000268	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CD4—psoriasis	2.04e-06	0.000259	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TP53—psoriasis	2.01e-06	0.000256	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—APOE—psoriasis	2e-06	0.000254	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PPARG—psoriasis	1.74e-06	0.000221	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—APOE—psoriasis	1.64e-06	0.000208	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—STAT3—psoriasis	1.58e-06	0.0002	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PPARG—psoriasis	1.42e-06	0.000181	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—IL6—psoriasis	1.1e-06	0.00014	CbGpPWpGaD
